InicioBION • SWX
add
BB Biotech 2nd Line Ord Shs
Cierre anterior
36,75 CHF
Intervalo diario
37,30 CHF - 38,30 CHF
Intervalo anual
34,50 CHF - 49,80 CHF
Cap. bursátil
2110,74 M CHF
Volumen medio
88,04 mil
Relación precio-beneficio
16,79
Rentabilidad por dividendo
5,25 %
Bolsa de valores principal
SWX
Noticias sobre los mercados
Información sobre la empresa
BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange.
It is one of the largest investment companies in the biotech sector. Wikipedia
Fundación
9 nov 1993
Sitio web
